Connection

ANANTH ANNAPRAGADA to Liposomes

This is a "connection" page, showing publications ANANTH ANNAPRAGADA has written about Liposomes.
Connection Strength

2.705
  1. A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging. J Alzheimers Dis. 2016; 52(2):731-45.
    View in: PubMed
    Score: 0.441
  2. Triggered release of ciprofloxacin from nanostructured agglomerated vesicles. Int J Nanomedicine. 2007; 2(3):407-18.
    View in: PubMed
    Score: 0.236
  3. Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats. Int J Nanomedicine. 2007; 2(3):501-13.
    View in: PubMed
    Score: 0.236
  4. Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J Control Release. 2005 Mar 02; 103(1):159-75.
    View in: PubMed
    Score: 0.205
  5. Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
    View in: PubMed
    Score: 0.136
  6. NIR-II fluorescence imaging using indocyanine green nanoparticles. Sci Rep. 2018 09 27; 8(1):14455.
    View in: PubMed
    Score: 0.133
  7. Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin a4?1. Sci Rep. 2018 02 27; 8(1):3733.
    View in: PubMed
    Score: 0.128
  8. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Placenta. 2017 Sep; 57:60-70.
    View in: PubMed
    Score: 0.122
  9. Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):285-94.
    View in: PubMed
    Score: 0.090
  10. Intravenous delivery of targeted liposomes to amyloid-? pathology in APP/PSEN1 transgenic mice. PLoS One. 2012; 7(10):e48515.
    View in: PubMed
    Score: 0.088
  11. Non inflammatory boronate based glucose-responsive insulin delivery systems. PLoS One. 2012; 7(1):e29585.
    View in: PubMed
    Score: 0.084
  12. TmDOTA-tetraglycinate encapsulated liposomes as pH-sensitive LipoCEST agents. PLoS One. 2011; 6(11):e27370.
    View in: PubMed
    Score: 0.083
  13. Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget. 2011 Apr; 2(4):298-304.
    View in: PubMed
    Score: 0.079
  14. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One. 2009 Oct 29; 4(10):e7628.
    View in: PubMed
    Score: 0.072
  15. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials. 2009 Aug; 30(23-24):3986-95.
    View in: PubMed
    Score: 0.069
  16. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration. Acad Radiol. 2008 Oct; 15(10):1259-63.
    View in: PubMed
    Score: 0.067
  17. Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats. J Control Release. 2006 Jun 28; 113(2):117-27.
    View in: PubMed
    Score: 0.056
  18. A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol. 2006 Feb; 186(2):300-7.
    View in: PubMed
    Score: 0.055
  19. Folate targeting of drug carriers: a mathematical model. J Control Release. 2005 May 05; 104(1):113-28.
    View in: PubMed
    Score: 0.053
  20. Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. J Control Release. 2003 Nov 18; 93(1):15-28.
    View in: PubMed
    Score: 0.048
  21. Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging. Acad Radiol. 2003 May; 10(5):475-83.
    View in: PubMed
    Score: 0.046
  22. Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
    View in: PubMed
    Score: 0.036
  23. Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent. Sci Rep. 2016 12 22; 6:38991.
    View in: PubMed
    Score: 0.029
  24. Data analysis: evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model. AMIA Annu Symp Proc. 2012; 2012:27-35.
    View in: PubMed
    Score: 0.022
  25. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS One. 2012; 7(4):e34496.
    View in: PubMed
    Score: 0.021
  26. Imaging of pulmonary embolism and t-PA therapy effects using MDCT and liposomal iohexol blood pool agent: preliminary results in a rabbit model. Acad Radiol. 2007 Mar; 14(3):355-62.
    View in: PubMed
    Score: 0.015
  27. High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. AJNR Am J Neuroradiol. 2007 Jan; 28(1):48-53.
    View in: PubMed
    Score: 0.015
  28. A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release. 2006 Sep 12; 114(3):277-87.
    View in: PubMed
    Score: 0.014
  29. Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med. 2006 May; 55(5):1023-9.
    View in: PubMed
    Score: 0.014
  30. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release. 2003 Sep 19; 92(1-2):49-67.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.